Vimarsana
Biggest News Aggregation in the World

Spectral Instruments Imaging News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Spectral Instruments Imaging. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Spectral Instruments Imaging Today - Breaking & Trending Today

Bruker Acquires Spectral Instruments Imaging - Vimarsana News

Bruker Acquires Spectral Instruments Imaging

Acquisition Complements Bruker’s Preclinical Imaging Portfolio with In-Vivo Optical Imaging

Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems - Vimarsana News

Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems

TUCSON, Ariz.--(BUSINESS WIRE)--Feb 6, 2024--

Preclinical Brain Imaging Market Trends, Research Report, Growth, Opportunities, Forecast 2022-2032 - Vimarsana News

Preclinical Brain Imaging Market Trends, Research Report, Growth, Opportunities, Forecast 2022-2032

Rockville, United States, 2022-Apr-28 (Latestmarketreports) – Preclinical Brain Imaging Market has been evolving and changing over the course of past few decades and the market scope has changed a lot over the course of time and to better understand the market’s current landscape this report on Preclinical Brain Ima...

Growing Prevalence Of Brain Cancer Is Expected To Drive Preclinical Brain Imaging Market Demand, Fac - Vimarsana News

Growing Prevalence Of Brain Cancer Is Expected To Drive Preclinical Brain Imaging Market Demand, Fac

Preclinical imaging is a technique used to monitor animals for research purposes such as in new drug development. Preclinical imaging includes many different imaging modalities, in which only few are suitable for imaging small animals, and others can be used in large animals. Preclinical imaging is used by researche...

Combination of tucatinib and neural stem cells secreting anti-HER2 antibody prolongs survival of mice with metastatic brain cancer - Vimarsana News

Combination of tucatinib and neural stem cells secreting anti-HER2 antibody prolongs survival of mice with metastatic brain cancer

Brain metastases are among the most severe complications of systemic breast cancer, and overexpression of the human epidermal growth factor receptor 2 (HER2) in breast cancer cells increases the incidence of brain metastases in patients. In this study, we engineered the human-derived, tumor cell tropic neural stem cells LM-NSC008 (LM008) to continuously secrete antibodies against HER2. These anti-HER2 antibodies impaired tumor cell proliferation by inhibiting the PI3K-Akt signaling pathway in HER2+ breast cancer cells in vitro. Importantly, our results demonstrate that the therapeutic combina...

Source: pnas.org